Gene: VAMP4
Official Full Name: vesicle associated membrane protein 4provided by HGNC
Gene Summary: Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. This protein may play a role in trans-Golgi network-to-endosome transport. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33957 | VAMP4 Knockout cell line (HeLa) | Human | VAMP4 | 1:3~1:6 | Negative | Online Inquiry |
KO33958 | VAMP4 Knockout cell line (HCT 116) | Human | VAMP4 | 1:2~1:4 | Negative | Online Inquiry |
KO33959 | VAMP4 Knockout cell line (HEK293) | Human | VAMP4 | 1:3~1:6 | Negative | Online Inquiry |
KO33960 | VAMP4 Knockout cell line (A549) | Human | VAMP4 | 1:3~1:4 | Negative | Online Inquiry |
VAMP4 Gene Knockout Cell Lines are specialized cellular models characterized by the targeted disruption of the VAMP4 gene, which encodes a vesicular soluble N-ethylmaleimide-sensitive factor attachment protein receptor (vSNARE) involved in intracellular trafficking. This gene knockout significantly impairs vesicle transport processes, thereby providing a powerful tool for dissecting the functional roles of VAMP4 in cellular physiology and pathology.
The primary mechanism behind these knockout cell lines lies in the CRISPR/Cas9 gene-editing technology, which ensures precise and efficient deletion of the VAMP4 gene. This targeted approach allows researchers to study the resulting phenotypic characteristics, such as changes in synaptic vesicle cycling, membrane fusion events, and neurotransmitter release dynamics, all of which are critical in understanding the molecular basis of various diseases, including neurodegenerative disorders and cancer.
In scientific research and clinical settings, VAMP4 Gene Knockout Cell Lines serve as pivotal resources for elucidating the cellular mechanisms underlying synaptic transmission and intracellular communication. The insights gained from these models can inform drug discovery and therapeutic strategies aimed at modulating synaptic functions. Furthermore, understanding the role of VAMP4 in cellular processes enhances our comprehension of fundamental biological pathways, making these cell lines invaluable for basic and translational research.
Compared to alternative gene editing methods or cell line models, VAMP4 Gene Knockout Cell Lines offer unmatched precision and reproducibility in experimental setups. The robustness of the CRISPR/Cas9 system provides high knockout efficiency, allowing for consistent results across studies. This reliability paves the way for more accurate interpretations of experimental data, ultimately leading to enhanced research outcomes.
For researchers and clinicians looking to expand their toolkits for studying molecular and cellular processes, the VAMP4 Gene Knockout Cell Lines offer a unique opportunity to explore intricate biological interactions. Leveraging our company’s extensive expertise in gene editing and cell line development, we provide high-quality, characterized cell lines that meet the rigorous demands of modern scientific research. Our dedication to advancing the life sciences ensures that scientists have access to the best tools for their groundbreaking studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.